Алгоритмы машинного обучения для виртуального раннего обнаружения и выявления нейродегенеративных и нейрокогнитивных расстройств: систематический обзор.

Introduction

Machine learning (ML) describes circumstances in which machines can mimic human minds in learning and analysis and thus be used to solve problems ( 1 ). Recent advances in ML have produced a computational framework by integrating a multitude of patient data and providing unique risk assessments and recommendations to each patient, which has the potential to revolutionize clinical decision-making ( 2 ) fundamentally.

Helping with diagnosis is one of the most significant uses of machine learning in this field. The promise of machine learning-based disease diagnosis (MLBDD), which is affordable and time-effective, is demonstrated by numerous researchers and practitioners ( 2 ). To identify chronic kidney disease, Ma et al. (2020) suggested a heterogeneous modified artificial neural network (HMANN) model that obtained an accuracy of 87–99% ( 3 ). To improve the diagnosis of COVID-19, Apostolopoulos and Mpesiana (2020) used a CNN-based Xception model on an imbalanced dataset of 284 COVID-19 and 967 non-COVID-19 patient chest X-ray images and achieved 89.6% accuracy in diagnosis ( 4 ). Regarding the diagnosis of diabetes, Yahyaoui et al. (2019) showed that the machine-learning RF technique works with an accuracy of 83.67% ( 5 ). The examples demonstrate how machine learning algorithms can provide more accurate and reliable disease diagnosis than other diagnostic techniques.

Neurodegenerative disorders are characterized by a gradual loss of neurons, often leading to death. The term covers a wide range of clinical diseases and progressive dementing conditions, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and a number of other neurological disorders ( 6 ). Neurocognitive disorders, including delirium, mild cognitive impairment and dementia, are characterized by a decrease in cognitive functioning from a previously attained level ( 7 ). Many of these diseases are incurable and sometimes fatal, but early detection can significantly improve the ability to control them.

AD is the most prevalent form of dementia. Patients with AD have trouble remembering things, which limits their ability to learn. Due to the slow progression of AD and the difficulty of current diagnostic techniques in identifying it in its early stages, early diagnosis of the disease is crucial.

PD is a progressive and chronic neurodegenerative disease. The overall validity of PD’s clinical diagnosis, particularly in the early stages of the disease, is unsatisfactory ( 8 ).

Delirium is acute brain dysfunction that causes cognitive impairment and shifting attention. Numerous symptoms, such as significant psychomotor agitation, a low level of consciousness, or both, may be present. Traditionally, one or more physicians’ evaluations have been used to diagnose delirium clinically. However, this method of diagnosis might contain flaws because of the disease’s unstable nature ( 9 ).

As evident, standard clinical diagnostic techniques for neurodegenerative and neurocognitive diseases have flaws, which make it difficult and occasionally impossible to diagnose the disease, especially in its early stages. On the other side, machine learning algorithms can be highly accurate when it comes to diagnosing a variety of diseases. Recently, many studies have been conducted on the efficacy of ML algorithms as a quick and reliable alternative diagnostic method. Therefore, in this article, we aimed to systematically assess different uses of ML algorithms in detecting neurodegenerative and neurocognitive disorders early.

Methods

This systematic review study was conducted as stated by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA2020) principles ( 10 ). This review has been registered on The Open Science Framework (OSF) (registration DOI https://osf.io/rtsyk/ ).

Information sources, search strategy

A comprehensive search of several databases was conducted from inception to August 15th, 2023. The databases included PubMed/MEDLINE, Scopus, Google Scholar and Web of Science. As seen in table 1 , the search for AI algorithms used for detecting and screening neurodegenerative and neurocognitive diseases involved a controlled vocabulary supplemented with keywords in each database. Table 1 demonstrates the specific search syntax used for each database involved.

Data screening and eligibility criteria

We used the RAYYAN intelligent tool for systematic reviews to screen the search results ( 11 ). Titles and abstracts from 7,069 articles obtained from our search strategy were independently and blindly screened by six reviewers (Zh.M., Sh.K., H.D., A.A., H.B., M.Y.). The duplicate records were removed using the same tool. The conflicts were resolved by a seventh reviewer (Sh.K.) using RAYYAN’s compute rating feature.

Inclusion criteria

The study was conducted on this specified list of neurodegenerative and neurocognitive diseases, and the search keywords included items below:

Huntington

Tauopathies and the subclassifications

Neurofibrillary tangles

Myelitis

Paraneoplastic polyneuropathy

Paraneoplastic cerebellar degeneration

Tourette syndrome

Neurofibromatoses

Encephalopathy

Neuropathy

ALS

Alzheimer’s disease (AD)

Mild cognitive impairment (MCI)

Parkinson’s disease (PD)

Frontotemporal dementia (FTD)

Lewy Body’s disease (LBD)

Progressive supranuclear palsy (PSP)

Corticobasal degeneration (CBD)

Wernicke-Korsakoff syndrome

Normal pressure hydrocephalus (NPH)

Prion diseases, such as Creutzfeldt-Jakob disease

Vascular dementia

Studies that were not available as open access were in languages other than English were conducted on animals, and were published as book chapters, Conference papers were excluded.

Quality assessment of included studies

Two assessors (MY and HD) evaluated each study separately based on the Cochrane risk of bias tool, evaluating all included studies ( 12 ). With a focus on six domains—sequence generation, allocation concealment, blinding, incomplete data, and selective reporting—the Cochrane risk of bias tool is a widely used and standard tool that contains all the necessary questions to evaluate methodological quality and bias risk. The two assessors settled other biases and disagreements through discussion and consensus.

Results

Study selection

Our search strategies in four databases yielded 7,069 studies, 1,365 were eliminated as duplicates. At least two individuals screened each of 4,334 remaining studies through title and abstract. Unrelated studies whose full text was unavailable, did not meet our inclusion criteria, and were not in English were excluded. At last, 108 studies were included for interpretation. Figure 1 depicts the study selection procedure.

Study characteristics

The included studies were published between 2015 and 2023. A study was carried out in Africa, another in Australia, 17 in Europe, 29 in America, and the remaining in Asia.

Findings

In the included studies, 3,723,329 participants were examined. Thirty-four studies on AD, 14 on PD, 13 on MCI, 10 on dementia, 7 on MS and the remaining studies were carried out on other neurodegenerative and neurocognitive disorders.

Dementia

In 10 studies conducted on dementia, 12 ML algorithms were used: XGBoost classification, Binary logistic regression (LR), A logistic model tree classifier combined with information gain feature selection, 3D convolutional neural networks (3D CNN), k-NearestNeighbor (kNN), support vector machine (SVM), random forest (RF), parallel recurrent convolutional neural network (PRCNN), support vector machine classifiers (SVC), support vector regression (SVR), partial least squares regression (PLSR) and Deep Neural Network (DNN), All of which showing promising results in early detection and screening of the disease. Table 2 summarizes our included studies.

SVM and XGBoost are prominent models for early dementia detection, each with distinct advantages and disadvantages regarding sensitivity and specificity. SVM excels in handling unbalanced datasets, achieving high sensitivity and specificity (over 90% in some studies), making identifying subtle early-stage symptoms practical. However, it can struggle with scalability and requires significant computational resources. In contrast, XGBoost offers flexibility and speed, handling various input features well, with sensitivities reaching between 80 and 85%. Yet, it may only perform in specificity compared to SVM if carefully tuned, which demands advanced cross-validation methods and more computational power. Both models demonstrate effectiveness; however, SVM offers enhanced specificity, which is vital for precise diagnostic accuracy. However, XGBoost excels in sensitivity but necessitates meticulous tuning to achieve optimal performance.

Parkinson’s disease

The ML algorithms used for PD are as follows: Center of Pressure, Load Distribution, Random forest algorithm, Neural Network (NN), Support vector machine, and affine registration using the FSL library developed by the Oxford Centre for Functional MRI of the Brain (FMRIB), Multi-Layer Perceptron (MLP), Vertical Ground Reaction Force (VGRF), logistic regression (LR), linear discriminant analysis (LDA), kNN, classification and regression tree (CART), Naive Bayes (NB), bagged decision tree (BDT), extra tree classifier (ETC), AdaBoost classifier (AC), gradient boosting classifier (GBC), Extremely Randomized Trees (ERT), Discriminant Analysis (DIS), Deep Learning (DEEP). All mentioned algorithms showed significant early PD detection, diagnosis and screening capabilities, and most had considerable sensitivity and specificity.

According to the review of studies, various algorithmic models have been employed for the early diagnosis of Parkinson’s disease, with deep learning models demonstrating exceptional effectiveness. These models achieve nearly 100% accuracy, along with high sensitivity and specificity. Their advantages include remarkable accuracy, non-invasive techniques utilizing medical imaging data, and automated feature extraction, which minimizes the need for manual data handling. However, deep learning models necessitate substantial computational resources and large volumes of labeled data, and their “black box” nature poses challenges for interpretability.

Alzheimer’s disease

In the included studies, much attention was paid to using ML algorithms for diagnosing and progressing Alzheimer’s. The following algorithms were used for detection, screening and progression of AD, all of which were successful for the purposes: Sequential minimal optimization (SMO), Naive Bayes (NB), tree augmented Naive Bayes (TAN), K2, MATLAB PatternRecognition toolbox, TF-IDF, CountVectorizer (CV), Word2Vec, FastText, VGG16 with XGB, stacked fusion models//hybrid stacked fusion model, PRS, AAO, KNN, decision tree, random forest, ANN, 3D-CNN model, Boruta FS algorithm, Gradient, Information Gain (IG), Multi-view Separable Pyramid Network (MiSePyNet), PyWinEA using Mono-objective and Multi-objective Genetic Algorithms (NSGAII), Elastic Net (EN), Gaussian Processes (GP), kNN, (LR), Linear Discriminant, Support Vector Machine, Voting classifiers, Multi-Classifier Network (MCN), Gradient Boosted Trees (GBTs), basic three-layer Neural Network architecture using the OASIS, Sparse K-means w/Resampling, a deep neural network architecture, Adaboost, graph convolutional and recurrent neural network (graph-CNN-RNN), Single hidden layer neural network, Single-layer bidirectional, LSTM, Three-layer CNN, Deep Belief Network (DBN), stacked auto-encoder (SAE), SVR, SVC, PLSR, Shallow Models, Feature Pyramid Network (FPN) and temporally structured SVM (TS-SVM).

Studies in our review suggested different algorithms for best accuracy to early detection of Alzheimer’s disease but Deep learning models especially CNNs, and SVM reported more effective than others. SVM and CNN each offer distinct advantages and limitations. SVM is advantageous due to its reliable classification accuracy and specificity, reaching about 93% accuracy and 87% sensitivity in some studies, making it efficient for handling smaller datasets with feature selection methods. However, it can struggle with high-dimensional data unless combined with dimensionality reduction techniques. In contrast, CNN models have shown high sensitivity and specificity in early detection of Alzheimer’s disease, with some studies reporting accuracies above 95%. Their advantages include high accuracy, automated feature extraction, and the non-invasive nature of using medical imaging data. However, these models require significant computational resources, large amounts of labeled data, and are often considered “black boxes” due to their lack of interpretability.

Mild cognitive impairment (MCI)

ML algorithms used for MCI included 3D-CNN, support vector machines, Gaussian Naive Bayes(GNB), EMCI identification framework, LASSO logistic regression, Naïve Bayes, Decision Tree, RF, Gaussian, Polynomial-kernel Support Vector Machines, kNN, LR, Adaboost and TS-SVM model. Except for LASSO logistic regression, all showed remarkable performance in early detection of the disease and its development to AD and dementia.

For the early detection of MCI, 3D-CNNs have proven to be highly effective, with studies demonstrating over 95% accuracy, high sensitivity and specificity. The advantages of CNNs include their ability to automatically extract relevant features from complex datasets and their non-invasive application of medical imaging. However, they require substantial computational resources and large amounts of labeled data, and their decision-making processes are often not easily interpretable, rendering them “black boxes.” SVMs are another viable option, offering moderate sensitivity and good interpretability. However, they necessitate extensive parameter tuning and may overlook fine spatial features critical for accurate diagnosis. RF and Decision Trees provide high interpretability and effectively manage non-linear data, though they typically exhibit lower sensitivity than CNN models. Ensemble methods, such as combinations of LASSO logistic regression and Naïve Bayes, offer a balanced approach in terms of sensitivity and specificity. These methods can serve as cost-effective options for initial screenings, particularly when integrated with clinical biomarkers. Overall, the choice of model should consider the trade-offs between performance, interpretability, and resource requirements to optimize early detection of MCI.

Random forest, LR, support vector machine, LightGBM, kNN, Decision tree, Gaussian Naïve Bayes (gNB), Auto-sklearn, Gaussian Processes (GP) regression, Gaussian Process regression (GPR), CNN, Adaboost, NN and LDR algorithms were also successfully used for detection and progression of Huntington’s disease, Multiple Sclerosis, Amyotrophic lateral sclerosis (ALS), Corticobasal Syndrome (CS), Neurofibromatosis type 1, Amyloid and Delirium.

Discussion

In this study, we investigated 108 studies evaluating patients with neurological diseases for early detection using ML algorithms. This study showcases specific and statistically significant findings to illustrate the progress in the area and the prospective influence of these advancements on the global management of neurocognitive and neurodegenerative illnesses.

AI technologies can retrieve data from medical texts and generate diagnostic and prediction models using this data. An extensive collection of electronic medical records amassed over a considerable period can serve as the fundamental data for this form of research ( 13 ). Traditional diagnostic methods for PD diagnosis may misdiagnose because they evaluate small movements that are hard to classify. Early non-motor symptoms of PD may be minor and caused by other illnesses. Thus, these symptoms are typically missed, making early PD diagnosis difficult. ML algorithms have been used to classify PD and healthy controls or patients with comparable clinical presentations to overcome these issues and improve PD diagnosis and evaluation. Multiple ML-based computer-aided diagnosis and detection (CADD) systems have shown promise in identifying PD patients from healthy controls ( 14 ). Using preclinical indicators of non-motor symptoms, including sleep Behavior Disorder (RBD) and olfactory loss, CSF measures, and dopaminergic imaging to classify early PD and healthy normal Prashanth et al. found SVM classification near-perfect ( 15 ). Balaji et al. proposed a multi-class learning technique that differs from earlier machine learning approaches, which often focus on binary classification to identify the existence of PD. In contrast, the proposed approach can not only classify but also quantify the stages of PD ( 16 ).

Individuals afflicted with MCI typically experience a deterioration in cognitive abilities, which significantly affects their general health. Importantly, failure to promptly identify this illness by medical professionals can readily progress into dementia. Using artificial intelligence, a dimensional assessment technique may seamlessly combine classical neuropsychological measurements and facilitate the diagnosis of AD ( 17 ). Similarly, Raees et al. present an initial automated deep learning system that utilizes a large MRI dataset of normal and 111 patients to predict AD. By evaluating the effectiveness of SVM and DNN models, they demonstrate that Deep learning has a significant level of accuracy, ranging from 80 to 90%, in predicting AD ( 18 ). Goenka and Tiwari introduced a three-class CNN that utilizes three computational approaches for neuroimaging to classify AD. Their suggested model was empirically validated, demonstrating classification accuracies of 97.48, 96.62, and 86.49% for big, medium, and small patches, respectively ( 19 ). Artificial neural networks revealed an intricate correlation between cognitive state and auditory function that cannot be easily anticipated only by considering the cognitive differences between individuals with and without AD ( 20 ).

Zhao et al. reported that Support Vector Machines (SVM), which integrate short-term clinical and brain MRI data, show potential in predicting the course of MS illness and identifying individuals who would benefit from more aggressive treatment approaches ( 21 ). Similarly, Law et al. found that the possibility of disability in MS was most accurately predicted using non-parametric machine learning techniques. It also can select those with the highest and lowest progression risk for inclusion in secondary progressive M.S. ( 22 ). Concordantly, Zhang et al. found that computational approaches (Lesion Segmentation Toolbox) provide more accurate conversion predictions from CIS to MS than human visual analysis ( 23 ). Goyal et al. utilized a machine learning technique to predict MS by analyzing serum cytokines. Their findings indicate that the RF model achieved an accuracy of 91%, suggesting its potential for predicting MS using serum cytokine levels. Moreover, the RF model demonstrated a 70% accuracy in classifying MS patients into remitting and non-remitting categories ( 24 ). These data were similar to other studies ( 25–27 ).

This comprehensive systematic study of 108 articles includes papers that illustrate significant patterns in using artificial intelligence for early detection of neurological illnesses. Therefore, the authors confine their focus to presenting factual information on utilizing AI techniques in various tasks without evaluating the quality of these investigations. Further studies are required to evaluate additional aspects, such as new neuroimaging measurements and blood and genetic biomarkers. The utilization of predictive algorithms, as detailed in this study, may enhance the development of collaborative visualization and decision-making tools for physicians and patients, as previously explored in another research. Future research could focus on decreasing the number of attributes without compromising accuracy. The proposed strategies can also be extended to tackle other chronic disorders. When creating AI models for medical issues, it is advisable to use simple computational methods with the available datasets to make it easier to implement the predictive tool in healthcare settings and solve economic issues.

Funding Statement

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.

Author contributions

MY: Writing – original draft, Writing – review & editing. MA: Writing – original draft, Writing – review & editing. ZM: Writing – original draft, Writing – review & editing. SK: Writing – original draft, Writing – review & editing. HD: Writing – original draft, Writing – review & editing. AA: Writing – original draft, Writing – review & editing. SS: Writing – original draft, Writing – review & editing. MAD: Writing – original draft, Writing – review & editing. HB: Writing – original draft, Writing – review & editing. NM: Writing – original draft, Writing – review & editing. SV: Writing – original draft, Writing – review & editing. ZR: Writing – original draft, Writing – review & editing. MAA: Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing. DS: Writing – original draft, Writing – review & editing, Validation, Conceptualization. AM: Writing – original draft, Validation, Writing – review & editing, Conceptualization.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Huang G, Huang G-B, Song S, You K. Trends in extreme learning machines: a review. Neural Netw. (2015) 61:32–48. doi: 10.1016/j.neunet.2014.10.001

2. Ahsan MM, Siddique Z. Machine learning-based heart disease diagnosis: a systematic literature review. Artif Intell Med. (2022) 128:102289. doi: 10.1016/j.artmed.2022.102289

3. Ma F, Sun T, Liu L, Jing H. Detection and diagnosis of chronic kidney disease using deep learning-based heterogeneous modified artificial neural network. Futur Gener Comput Syst. (2020) 111:17–26. doi: 10.1016/j.future.2020.04.036

4. Apostolopoulos ID, Mpesiana TA. COVID-19: automatic detection from x-ray images utilizing transfer learning with convolutional neural networks. Physical Engin Sci Med. (2020) 43:635–40. doi: 10.1007/s13246-020-00865-4, PMID:

5. Yahyaoui A, Jamil A, Rasheed J, Yesiltepe M, editors. A decision support system for diabetes prediction using machine learning and deep learning techniques. In 2019 1st international informatics and software engineering conference (UBMYK) (2019)

6. Mendez MF, McMurtray AM. Neurodegenerative Disorders In: Fink G, editor. Encyclopedia of stress. Second ed. New York: Academic Press; (2007). 840–4.

7. Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. (2014) 10:634–42. doi: 10.1038/nrneurol.2014.181

8. Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. (2016) 86:566–76. doi: 10.1212/WNL.0000000000002350

9. Zou Y, Cole MG, Primeau FJ, McCusker J, Bellavance F, Laplante J. Detection and diagnosis of delirium in the elderly: psychiatrist diagnosis, confusion assessment method, or consensus diagnosis? Int Psychogeriatr. (1998) 10:303–8. doi: 10.1017/S1041610298005390

10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. (2021) 88:105906. doi: 10.1016/j.ijsu.2021.105906, PMID:

11. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. (2016) 5:1–10. doi: 10.1186/s13643-016-0384-4

12. Gingras-Charland M-E, Côté A-M, Girard P, Grenier A, Pasquier J-C, Sauvé N. Pre-eclampsia educational tool impact on knowledge, anxiety, and satisfaction in pregnant women: a randomized trial. J Obstet Gynaecol Can. (2019) 41:960–70. doi: 10.1016/j.jogc.2018.10.003

13. Danilov G, Shifrin M, Kotik K, Ishankulov T, Orlov YN, Kulikov A, et al. Artificial intelligence technologies in neurosurgery: a systematic literature review using topic modeling. Part II: research objectives and perspectives. Mod Technol Med. (2020) 12:111. doi: 10.17691/stm2020.12.6.12

14. Dash S. A systematic review of adaptive machine learning techniques for early detection of Parkinson's disease. Artificial Intelligence Neurol Disord. (2023):361–85. doi: 10.1016/B978-0-323-90277-9.00018-3

15. Prashanth R, Roy SD, Mandal PK, Ghosh S. High-accuracy detection of early Parkinson's disease through multimodal features and machine learning. Int J Med Inform. (2016) 90:13–21. doi: 10.1016/j.ijmedinf.2016.03.001, PMID:

16. Balaji E, Brindha D, Balakrishnan R. Supervised machine learning based gait classification system for early detection and stage classification of Parkinson’s disease. Appl Soft Comput. (2020) 94:106494. doi: 10.1016/j.asoc.2020.106494

17. Cavedoni S, Chirico A, Pedroli E, Cipresso P, Riva G. Digital biomarkers for the early detection of mild cognitive impairment: artificial intelligence meets virtual reality. Front Hum Neurosci. (2020) 14:245. doi: 10.3389/fnhum.2020.00245, PMID:

18. Raees PM, Thomas V. Automated detection of Alzheimer’s disease using deep learning in MRI. J Phys Conf Ser. (2021). doi: 10.1088/1742-6596/1921/1/012024

19. Goenka N, Tiwari S. AlzVNet: a volumetric convolutional neural network for multiclass classification of Alzheimer’s disease through multiple neuroimaging computational approaches. Biomed Signal Process Control. (2022) 74:103500. doi: 10.1016/j.bspc.2022.103500

20. Krishnamurti S, Drake L, King J. Neural network modeling of central auditory dysfunction in Alzheimer’s disease. Neural Netw. (2011) 24:646–51. doi: 10.1016/j.neunet.2011.02.010

21. Zhao Y, Healy BC, Rotstein D, Guttmann CR, Bakshi R, Weiner HL, et al. Exploration of machine learning techniques in predicting multiple sclerosis disease course. PLoS One. (2017) 12:e0174866. doi: 10.1371/journal.pone.0174866, PMID:

22. Law MT, Traboulsee AL, Li DK, Carruthers RL, Freedman MS, Kolind SH, et al. Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression. Multiple Sclerosis J Experiment Transl Clin. (2019) 5:2055217319885983. doi: 10.1177/2055217319885983

23. Zhang H, Alberts E, Pongratz V, Mühlau M, Zimmer C, Wiestler B, et al. Predicting conversion from clinically isolated syndrome to multiple sclerosis–an imaging-based machine learning approach. NeuroImage. (2019) 21:101593. doi: 10.1016/j.nicl.2018.11.003, PMID:

24. Goyal M, Khanna D, Rana PS, Khaibullin T, Martynova E, Rizvanov AA, et al. Computational intelligence technique for prediction of multiple sclerosis based on serum cytokines. Front Neurol. (2019) 10:781. doi: 10.3389/fneur.2019.00781

25. Vázquez-Marrufo M, Sarrias-Arrabal E, García-Torres M, Martín-Clemente R, Izquierdo G. A systematic review of the application of machine-learning algorithms in multiple sclerosis. Neurología. (2022) 38:577–90. doi: 10.1016/j.nrleng.2020.10.013

26. Trentzsch K, Schumann P, Śliwiński G, Bartscht P, Haase R, Schriefer D, et al. Using machine learning algorithms for identifying gait parameters suitable to evaluate subtle changes in gait in people with multiple sclerosis. Brain Sci. (2021) 11:1049. doi: 10.3390/brainsci11081049, PMID:

27. Moazami F, Lefevre-Utile A, Papaloukas C, Soumelis V. Machine learning approaches in study of multiple sclerosis disease through magnetic resonance images. Front Immunol. (2021) 12:700582. doi: 10.3389/fimmu.2021.700582, PMID:

28. Gao XR, Chiariglione M, Qin K, Nuytemans K, Scharre DW, Li YJ, et al. Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer's disease prediction. Sci Rep. (2023) 13:450. doi: 10.1038/s41598-023-27551-1, PMID:

29. Fayemiwo MA, Olowookere TA, Olaniyan OO, Ojewumi TO. Oyetade IS, Freeman S, et al. Immediate word recall in cognitive assessment can predict dementia using machine learning techniques. Alzheimers Res Ther. (2023) 15:111. doi: 10.1186/s13195-023-01250-5, PMID:

30. Bhandari N, Walambe R, Kotecha K, Kaliya M. Integrative gene expression analysis for the diagnosis of Parkinson's disease using machine learning and explainable AI. Comput Biol Med. (2023) 163:107140. doi: 10.1016/j.compbiomed.2023.107140, PMID:

31. Li Q, Yang X, Xu J, Guo Y, He X, Hu H, et al. Early prediction of Alzheimer's disease and related dementias using real-world electronic health records. Alzheimers Dement. (2023) 19:3506–18. doi: 10.1002/alz.12967

32. Ostertag C, Visani M, Urruty T, Beurton-Aimar M. Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: transfer learning from Alzheimer's disease to Parkinson's disease. Int J Comput Assist Radiol Surg. (2023) 18:809–18. doi: 10.1007/s11548-023-02866-6, PMID:

33. Ponce de Leon-Sanchez ER, Dominguez-Ramirez OA, Herrera-Navarro AM, Rodriguez-Resendiz J, Paredes-Orta C, Mendiola-Santibañez JD. A deep learning approach for predicting multiple sclerosis. Micromachines (Basel). (2023) 14:749. doi: 10.3390/mi14040749

34. Russo M, Amboni M, Barone P, Pellecchia MT, Romano M, Ricciardi C, et al. Identification of a gait pattern for detecting mild cognitive impairment in Parkinson's disease. Sensors. (2023) 23:1985. doi: 10.3390/s23041985, PMID:

35. Syam V, Safal S, Bhutia O, Singh AK, Giri D, Bhandari SS, et al. A non-invasive method for prediction of neurodegenerative diseases using gait signal features. Procedia Comput Sci. (2023) 218:1529–41. doi: 10.1016/j.procs.2023.01.131, PMID:

36. Tan WY, Hargreaves C, Chen C, Hilal S. A machine learning approach for early diagnosis of cognitive impairment using population-based data. J Alzheimers Dis. (2023) 91:449–61. doi: 10.3233/JAD-220776, PMID:

37. Tayyab M, Metz LM, Li DKB, Kolind S, Carruthers R, Traboulsee A, et al. Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis. Front Neurol. (2023) 14:1165267. doi: 10.3389/fneur.2023.1165267, PMID:

38. Tena A, Clarià F, Solsona F, Povedano M. Voiceprint and machine learning models for early detection of bulbar dysfunction in ALS. Comput Methods Prog Biomed. (2023) 229:107309. doi: 10.1016/j.cmpb.2022.107309, PMID:

39. Mueller B, Street WN, Carnahan RM, Lee S. Evaluating the performance of machine learning methods for risk estimation of delirium in patients hospitalized from the emergency department. Acta Psychiatr Scand. (2023) 147:493–505. doi: 10.1111/acps.13551, PMID:

40. Swarnalatha R. A greedy optimized intelligent framework for early detection of Alzheimer's disease using EEG signal. Comput Intell Neurosci. (2023) 2023:4808841. doi: 10.1155/2023/4808841, PMID:

41. Ahmed H, Soliman H, El-Sappagh S, Abuhmed T, Elmogy M. Early detection of Alzheimer's disease based on Laplacian re-decomposition and XGBoosting. Comput Syst Sci Engin. (2023) 46:2773–95. doi: 10.32604/csse.2023.036371

42. Ahmed H, Soliman H, Elmogy M. Early detection of Alzheimer's disease using single nucleotide polymorphisms analysis based on gradient boosting tree. Comput Biol Med. (2022) 146:105622. doi: 10.1016/j.compbiomed.2022.105622, PMID:

43. García-Gutierrez F, Díaz-Álvarez J, Matias-Guiu JA, Pytel V, Matías-Guiu J, Cabrera-Martín MN, et al. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer's disease and frontotemporal dementia using genetic algorithms. Med Biol Eng Comput. (2022) 60:2737–56. doi: 10.1007/s11517-022-02630-z, PMID:

44. Kavitha C, Mani V, Srividhya SR, Khalaf OI, Tavera Romero CA. Early-stage Alzheimer's disease prediction using machine learning models. Front Public Health. (2022) 10:853294. doi: 10.3389/fpubh.2022.853294, PMID:

45. Kumar MR, Vekkot S, Lalitha S, Gupta D, Govindraj VJ, Shaukat K, et al. Dementia detection from speech using machine learning and deep learning architectures. Sensors. (2022) 22:9311. doi: 10.3390/s22239311, PMID:

46. Li Z, Li H, Braimah A, Dillman JR, Parikh NA, He L. A novel ontology-guided attribute partitioning ensemble learning model for early prediction of cognitive deficits using quantitative structural MRI in very preterm infants. NeuroImage. (2022) 260:119484. doi: 10.1016/j.neuroimage.2022.119484, PMID:

47. Liu S, Schlesinger JJ, McCoy AB, Reese TJ, Steitz B, Russo E, et al. New onset delirium prediction using machine learning and long short-term memory (LSTM) in electronic health record. J Am Med Inform Assoc. (2022) 30:120–31. doi: 10.1093/jamia/ocac210, PMID:

48. Mehra N, Mittal P. Design and implementation of ML model for early diagnosis of Parkinson’s disease using gait data analysis in IoT environment. Int J Adv Comput Sci Appl. (2022) 13:580–9. doi: 10.14569/IJACSA.2022.0130769

49. Nelson CA, Bove R, Butte AJ, Baranzini SE. Embedding electronic health records onto a knowledge network recognizes prodromal features of multiple sclerosis and predicts diagnosis. J Am Med Inform Assoc. (2022) 29:424–34. doi: 10.1093/jamia/ocab270, PMID:

50. Penfold RB, Carrell DS, Cronkite DJ, Pabiniak C, Dodd T, Glass AM, et al. Development of a machine learning model to predict mild cognitive impairment using natural language processing in the absence of screening. BMC Med Inform Decis Mak. (2022) 22:129. doi: 10.1186/s12911-022-01864-z, PMID:

51. Qiu A, Xu L, Liu C. Predicting diagnosis 4 years prior to Alzheimer's disease incident. Neuroimage Clin. (2022) 34:102993. doi: 10.1016/j.nicl.2022.102993, PMID:

52. Revathi A, Kaladevi R, Ramana K, Jhaveri RH, Rudra Kumar M, Kumar SP, et al. Early detection of cognitive decline using machine learning algorithm and cognitive ability test. Secur Commun Networks. (2022) 2022:1–13. doi: 10.1155/2022/4190023

53. Riad R, Lunven M, Titeux H, Cao XN, Hamet Bagnou J, Lemoine L, et al. Predicting clinical scores in Huntington's disease: a lightweight speech test. J Neurol. (2022) 269:5008–21. doi: 10.1007/s00415-022-11148-1, PMID:

54. Schumann P, Scholz M, Trentzsch K, Jochim T, Śliwiński G, Malberg H, et al. Detection of fall risk in multiple sclerosis by gait analysis-an innovative approach using feature selection ensemble and machine learning algorithms. Brain Sci. (2022) 12:1477. doi: 10.3390/brainsci12111477, PMID:

55. Sun X, Ren X, Zhang J, Nie Y, Hu S, Yang X, et al. Discovering miRNAs associated with multiple sclerosis based on network representation learning and deep learning methods. Front Genet. (2022) 13:899340. doi: 10.3389/fgene.2022.899340, PMID:

56. Tufail AB, Anwar N, Othman MTB, Ullah I, Khan RA, Ma YK, et al. Early-stage Alzheimer's disease categorization using PET neuroimaging modality and convolutional neural networks in the 2D and 3D domains. Sensors. (2022) 22:4609. doi: 10.3390/s22124609, PMID:

57. Wang Q, Xu R. AANet: attentive all-level fusion deep neural network approach for multi-modality early Alzheimer's disease diagnosis. AMIA Annu Symp Proc. (2022) 2022:1125–34. doi: 10.1016/j.matpr.2021.03.06118

58. Yu X, Srivastava S, Huang S, Hayden EY, Teplow DB, Xie YH. The feasibility of early Alzheimer's disease diagnosis using a neural network hybrid platform. Biosensors. (2022) 12:753. doi: 10.3390/bios12090753

59. Zhang W, Shen J, Wang Y, Cai K, Zhang Q, Cao M. Blood SSR1: a possible biomarker for early prediction of Parkinson's disease. Front Mol Neurosci. (2022) 15:762544. doi: 10.3389/fnmol.2022.762544, PMID:

60. Valencia L, Clèrigues A, Valverde S, Salem M, Oliver A, Rovira À, et al. Evaluating the use of synthetic T1-w images in new T2 lesion detection in multiple sclerosis. Front Neurosci. (2022) 16:954662. doi: 10.3389/fnins.2022.954662, PMID:

61. Adhikari S, Thapa S, Naseem U, Singh P, Huo H, Bharathy G, et al. Exploiting linguistic information from Nepali transcripts for early detection of Alzheimer's disease using natural language processing and machine learning techniques. Int J Hum Comput Stud. (2022) 160:102761. doi: 10.1016/j.ijhcs.2021.102761

62. Alkenani AH, Li Y, Xu Y, Zhang Q. Predicting Alzheimer's disease from spoken and written language using fusion-based stacked generalization. J Biomed Inform. (2021) 118:103803. doi: 10.1016/j.jbi.2021.103803, PMID:

63. Etminani K, Soliman A, Davidsson A, Chang JR, Martínez-Sanchis B, Byttner S, et al. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. Eur J Nucl Med Mol Imaging. (2022) 49:563–84. doi: 10.1007/s00259-021-05483-0, PMID:

64. Herzog NJ, Magoulas GD. Brain asymmetry detection and machine learning classification for diagnosis of early dementia. Sensors. (2021) 21:778. doi: 10.3390/s21030778, PMID:

65. James C, Ranson JM, Everson R, Llewellyn DJ. Performance of machine learning algorithms for predicting progression to dementia in memory clinic patients. JAMA Netw Open. (2021) 4:e2136553. doi: 10.1001/jamanetworkopen.2021.36553, PMID:

66. Kleiman MJ, Barenholtz E, Galvin JE. Screening for early-stage Alzheimer's disease using optimized feature sets and machine learning. J Alzheimers Dis. (2021) 81:355–66. doi: 10.3233/JAD-201377, PMID:

67. Noh B, Yoon H, Youm C, Kim S, Lee M, Park H, et al. Prediction of decline in global cognitive function using machine learning with feature ranking of gait and physical fitness outcomes in older adults. Int J Environ Res Public Health. (2021) 18:11347. doi: 10.3390/ijerph182111347, PMID:

68. Roshanzamir A, Aghajan H, Soleymani BM. Transformer-based deep neural network language models for Alzheimer's disease risk assessment from targeted speech. BMC Med Inform Decis Mak. (2021) 21:92. doi: 10.1186/s12911-021-01456-3, PMID:

69. Sánchez-Reyna AG, Celaya-Padilla JM, Galván-Tejada CE, Luna-García H, Gamboa-Rosales H, Ramirez-Morales A, et al. Multimodal early Alzheimer's detection, a genetic algorithm approach with support vector machines. Healthcare. (2021) 9:971. doi: 10.3390/healthcare9080971

70. Singhania U, Tripathy B, Hasan MK, Anumbe NC, Alboaneen D, Ahmed FRA, et al. A predictive and preventive model for onset of Alzheimer's disease. Front Public Health. (2021) 9:751536. doi: 10.3389/fpubh.2021.751536, PMID:

71. Syed ZS, Syed MSS, Lech M, Pirogova E. Automated recognition of Alzheimer's dementia using bag-of-deep-features and model Ensembling. IEEE Access. (2021) 9:88377–90. doi: 10.1109/ACCESS.2021.3090321

72. Tsai CF, Chen CC, Wu EH, Chung CR, Huang CY, Tsai PY, et al. A machine-learning-based assessment method for early-stage neurocognitive impairment by an immersive virtual supermarket. IEEE Trans Neural Syst Rehabil Eng. (2021) 29:2124–32. doi: 10.1109/TNSRE.2021.3118918

73. Uehara Y, Ueno SI, Amano-Takeshige H, Suzuki S, Imamichi Y, Fujimaki M, et al. Non-invasive diagnostic tool for Parkinson's disease by sebum RNA profile with machine learning. Sci Rep. (2021) 11:18550. doi: 10.1038/s41598-021-98423-9, PMID:

74. Venugopalan J, Tong L, Hassanzadeh HR, Wang MD. Multimodal deep learning models for early detection of Alzheimer's disease stage. Sci Rep. (2021) 11:3254. doi: 10.1038/s41598-020-74399-w, PMID:

75. Wang L, Laurentiev J, Yang J, Lo YC, Amariglio RE, Blacker D, et al. Development and validation of a deep learning model for earlier detection of cognitive decline from clinical notes in electronic health records. JAMA Netw Open. (2021) 4:e2135174. doi: 10.1001/jamanetworkopen.2021.35174, PMID:

76. Zhu Y, Kim M, Zhu X, Kaufer D, Wu G. Long range early diagnosis of Alzheimer's disease using longitudinal MR imaging data. Med Image Anal. (2021) 67:101825. doi: 10.1016/j.media.2020.101825, PMID:

77. Mehmood A, Yang S, Feng Z, Wang M, Ahmad AS, Khan R, et al. A transfer learning approach for early diagnosis of Alzheimer's disease on MRI images. Neuroscience. (2021) 460:43–52. doi: 10.1016/j.neuroscience.2021.01.002

78. Montolío A, Martín-Gallego A, Cegoñino J, Orduna E, Vilades E, Garcia-Martin E, et al. Machine learning in diagnosis and disability prediction of multiple sclerosis using optical coherence tomography. Comput Biol Med. (2021) 133:104416. doi: 10.1016/j.compbiomed.2021.104416

79. Sudharsan M, Thailambal G. Alzheimer's disease prediction using machine learning techniques and principal component analysis (PCA). Materials Today. (2021) 133:104416. doi: 10.1016/j.matpr.2021.03.061

80. Wang R, Luo W, Liu Z, Liu W, Liu C, Liu X, et al. Integration of the extreme gradient boosting model with electronic health records to enable the early diagnosis of multiple sclerosis. Mult Scler Relat Disord. (2021) 47:102632. doi: 10.1016/j.msard.2020.102632

81. Zeng A, Rong H, Pan D, Jia L, Zhang Y, Zhao F, et al. Discovery of genetic biomarkers for Alzheimer's disease using adaptive convolutional neural networks ensemble and genome-wide association studies. Interdiscip Sci. (2021) 13:787–800. doi: 10.1007/s12539-021-00470-3

82. Peng Y, Zheng Y, Tan Z, Liu J, Xiang Y, Liu H, et al. Prediction of unenhanced lesion evolution in multiple sclerosis using radiomics-based models: a machine learning approach. Mult Scler Relat Disord. (2021) 53:102989. doi: 10.1016/j.msard.2021.102989

83. Lee J, Ko W, Kang E, Suk HI. A unified framework for personalized regions selection and functional relation modeling for early MCI identification. NeuroImage. (2021) 236:118048. doi: 10.1016/j.neuroimage.2021.118048

84. Buegler M, Harms R, Balasa M, Meier IB, Exarchos T, Rai L, et al. Digital biomarker-based individualized prognosis for people at risk of dementia. Alzheimers Dement. (2020) 12:e12073. doi: 10.1002/dad2.12073, PMID:

85. Alkhatib R, Diab MO, Corbier C, El Badaoui M. Machine learning algorithm for gait analysis and classification on early detection of Parkinson. IEEE Sensors Letters. (2020) 4:1–4. doi: 10.1109/LSENS.2020.299493835582432

86. Gill S, Mouches P, Hu S, Rajashekar D, MacMaster FP, Smith EE, et al. Using machine learning to predict dementia from neuropsychiatric symptom and neuroimaging data. J Alzheimers Dis. (2020) 75:277–88. doi: 10.3233/JAD-191169, PMID:

87. Cheng J, Liu HP, Lin WY, Tsai FJ. Identification of contributing genes of Huntington's disease by machine learning. BMC Med Genet. (2020) 13:176. doi: 10.1186/s12920-020-00822-w, PMID:

88. Pan X, Phan TL, Adel M, Fossati C, Gaidon T, Wojak J, et al. Multi-view separable pyramid network for AD prediction at MCI stage by (18)F-FDG brain PET imaging. IEEE Trans Med Imaging. (2021) 40:81–92. doi: 10.1109/TMI.2020.3022591

89. Balea-Fernandez FJ, Martinez-Vega B, Ortega S, Fabelo H, Leon R, Callico GM, et al. Analysis of risk factors in dementia through machine learning. J Alzheimers Dis. (2021) 79:845–61. doi: 10.3233/JAD-200955

90. Jauk S, Kramer D, Großauer B, Rienmüller S, Avian A, Berghold A, et al. Risk prediction of delirium in hospitalized patients using machine learning: an implementation and prospective evaluation study. J Am Med Inform Assoc. (2020) 27:1383–92. doi: 10.1093/jamia/ocaa113, PMID:

91. Liu J, Tan G, Lan W, Wang J. Identification of early mild cognitive impairment using multi-modal data and graph convolutional networks. BMC Bioinform. (2020) 21:123. doi: 10.1186/s12859-020-3437-6, PMID:

92. Martynova E, Goyal M, Johri S, Kumar V, Khaibullin T, Rizvanov AA, et al. Serum and cerebrospinal fluid cytokine biomarkers for diagnosis of multiple sclerosis. Mediat Inflamm. (2020) 2020:1–10. doi: 10.1155/2020/2727042

93. Pelka O, Friedrich CM, Nensa F, Mönninghoff C, Bloch L, Jöckel KH, et al. Sociodemographic data and APOE-ε4 augmentation for MRI-based detection of amnestic mild cognitive impairment using deep learning systems. PLoS One. (2020) 15:e0236868. doi: 10.1371/journal.pone.0236868, PMID:

94. Wang W, Lee J, Harrou F, Sun Y. Early detection of Parkinson's disease using deep learning and machine learning. IEEE Access. (2020) 8:147635–46. doi: 10.1109/ACCESS.2020.3016062

95. Zhu F, Li X, McGonigle D, Tang H, He Z, Zhang C, et al. Analyze informant-based questionnaire for the early diagnosis of senile dementia using deep learning. IEEE J Transl Eng Health Med. (2020) 8:1–6. doi: 10.1109/JTEHM.2019.2959331

96. Magesh PR, Myloth RD, Tom RJ. An explainable machine learning model for early detection of Parkinson's disease using LIME on DaTSCAN imagery. Comput Biol Med. (2020) 126:104041. doi: 10.1016/j.compbiomed.2020.104041, PMID:

97. Marziyeh Ghoreshi Beyrami S, Ghaderyan P. A robust, cost-effective and non-invasive computer-aided method for diagnosis three types of neurodegenerative diseases with gait signal analysis. Measurement. (2020):156. doi: 10.1016/j.measurement.2020.107579

98. Roca P, Attye A, Colas L, Tucholka A, Rubini P, Cackowski S, et al. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI. Diagn Interv Imaging. (2020) 101:795–802. doi: 10.1016/j.diii.2020.05.009

99. Park C, Ha J, Park S. Prediction of Alzheimer's disease based on deep neural network by integrating gene expression and DNA methylation dataset. Expert Syst Appl. (2020) 140:112873. doi: 10.1016/j.eswa.2019.112873

100. Braga D, Madureira AM, Coelho L, Ajith R. Automatic detection of Parkinson’s disease based on acoustic analysis of speech. Eng Appl Artif Intell. (2019) 77:148–58. doi: 10.1016/j.engappai.2018.09.018

101. Abd El Hamid MM, Mabrouk MS, Omar YM. Developing an early predictive system for identifying genetic biomarkers associated to Alzheimer’s disease using machine learning techniques. Biomed Engin. (2019) 31:1950040. doi: 10.4015/S1016237219500406

102. Bi X, Wang H. Early Alzheimer's disease diagnosis based on EEG spectral images using deep learning. Neural Netw. (2019) 114:119–35. doi: 10.1016/j.neunet.2019.02.005, PMID:

103. Maitra S, Hossain T, Al-Sakin A, Inzamamuzzaman S, Or Rashid MM, Hasan SS. A gender-neutral approach to detect early Alzheimer's disease applying a three-layer NN. Int J Adv Comput Sci Appl. (2019) 10:530–8. doi: 10.14569/IJACSA.2019.0100368

104. Pérez Del Palomar A, Cegoñino J, Montolío A, Orduna E, Vilades E, Sebastián B, et al. Swept source optical coherence tomography to early detect multiple sclerosis disease. The use of machine learning techniques. PLoS One. (2019) 14:e0216410. doi: 10.1371/journal.pone.0216410, PMID:

105. Petrone PM, Casamitjana A, Falcon C, Artigues M, Operto G, Cacciaglia R, et al. Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI. Alzheimers Res Ther. (2019) 11:72. doi: 10.1186/s13195-019-0526-8, PMID:

106. Prasad BS. Supervised machine learning algorithms for early diagnosis of Alzheimer’s disease. Int J Recent Technol Engin. (2019) 8:7964–7. doi: 10.35940/ijrte.c6646.098319

107. Rehman RZU, Del Din S, Guan Y, Yarnall AJ, Shi JQ, Rochester L. Selecting clinically relevant gait characteristics for classification of early Parkinson's disease: a comprehensive machine learning approach. Sci Rep. (2019) 9:17269. doi: 10.1038/s41598-019-53656-7, PMID:

108. Shen T, Jiang J, Lu J, Wang M, Zuo C, Yu Z, et al. Predicting Alzheimer disease from mild cognitive impairment with a deep belief network based on 18F-FDG-PET images. Mol Imaging. (2019) 18:1536012119877285. doi: 10.1177/1536012119877285, PMID:

109. Spasov S, Passamonti L, Duggento A, Liò P, Toschi N. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease. NeuroImage. (2019) 189:276–87. doi: 10.1016/j.neuroimage.2019.01.031, PMID:

110. Peña-Bautista C, Durand T, Oger C, Baquero M, Vento M, Cháfer-Pericás C. Assessment of lipid peroxidation and artificial neural network models in early Alzheimer disease diagnosis. Clin Biochem. (2019) 72:64–70. doi: 10.1016/j.clinbiochem.2019.07.008, PMID:

111. Saccà V, Sarica A, Novellino F, Barone S, Tallarico T, Filippelli E, et al. Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data. Brain Imaging Behav. (2019) 13:1103–14. doi: 10.1007/s11682-018-9926-9, PMID:

112. Cai Z, Gu J, Wen C, Zhao D, Huang C, Huang H, et al. An intelligent Parkinson's disease diagnostic system based on a chaotic bacterial foraging optimization enhanced fuzzy KNN approach. Comput Math Methods Med. (2018) 2018:1–24. doi: 10.1155/2018/2396952

113. Amoroso N, La Rocca M, Monaco A, Bellotti R, Tangaro S. Complex networks reveal early MRI markers of Parkinson's disease. Med Image Anal. (2018) 48:12–24. doi: 10.1016/j.media.2018.05.004, PMID:

114. Bairagi V. EEG signal analysis for early diagnosis of Alzheimer disease using spectral and wavelet based features. Int J Inf Technol. (2018) 10:403–12. doi: 10.1007/s41870-018-0165-5

115. Parisi L, RaviChandran N, Manaog ML. Feature-driven machine learning to improve early diagnosis of Parkinson's disease. Expert Syst Appl. (2018) 110:182–90. doi: 10.1016/j.eswa.2018.06.003

116. Grassi M, Perna G, Caldirola D, Schruers K, Duara R, Loewenstein DA. A clinically-translatable machine learning algorithm for the prediction of Alzheimer's disease conversion in individuals with mild and premild cognitive impairment. J Alzheimers Dis. (2018) 61:1555–73. doi: 10.3233/JAD-170547, PMID:

117. He L, Li H, Holland SK, Yuan W, Altaye M, Parikh NA. Early prediction of cognitive deficits in very preterm infants using functional connectome data in an artificial neural network framework. Neuroimage Clin. (2018) 18:290–7. doi: 10.1016/j.nicl.2018.01.032, PMID:

118. Schütze M, de Souza CD, de Paula JJ, Malloy-Diniz LF, Malamut C, Mamede M, et al. Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1. PLoS One. (2018) 13:e0203520. doi: 10.1371/journal.pone.0203520

119. Oh J, Cho D, Park J, Na SH, Kim J, Heo J, et al. Prediction and early detection of delirium in the intensive care unit by using heart rate variability and machine learning. Physiol Meas. (2018) 39:035004. doi: 10.1088/1361-6579/aaab07, PMID:

120. Lu D, Popuri K, Ding GW, Balachandar R, Beg MF. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease. Med Image Anal. (2018) 46:26–34. doi: 10.1016/j.media.2018.02.002, PMID:

121. Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, et al. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure. NeuroImage. (2017) 161:171–8. doi: 10.1016/j.neuroimage.2017.07.050, PMID:

122. Pereira T, Lemos L, Cardoso S, Silva D, Rodrigues A, Santana I, et al. Predicting progression of mild cognitive impairment to dementia using neuropsychological data: a supervised learning approach using time windows. BMC Med Inform Decis Mak. (2017) 17:110. doi: 10.1186/s12911-017-0497-2

123. Peng B, Wang SH, Zhou ZY, Liu Y, Tong BT, Zhang T, et al. A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease. Neurosci Lett. (2017) 651:88–94. doi: 10.1016/j.neulet.2017.04.034, PMID:

124. Zhu Y, Zhu X, Kim M, Shen D, Wu G. Early diagnosis of Alzheimer's disease by joint feature selection and classification on temporally structured support vector machine. Med Image Comput Comput Assist Interv. (2016) 9900:264–72. doi: 10.1007/978-3-319-46720-7_31, PMID:

125. Cabral C, Morgado PM, Campos Costa D, Silveira M. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages. Comput Biol Med. (2015) 58:101–9. doi: 10.1016/j.compbiomed.2015.01.003, PMID:

126. Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. NeuroImage. (2015) 104:398–412. doi: 10.1016/j.neuroimage.2014.10.002, PMID:

127. Suk HI, Lee SW, Shen D. Latent feature representation with stacked auto-encoder for AD/MCI diagnosis. Brain Struct Funct. (2015) 220:841–59. doi: 10.1007/s00429-013-0687-3, PMID:

128. Maestú F, Peña JM, Garcés P, González S, Bajo R, Bagic A, et al. A multicenter study of the early detection of synaptic dysfunction in mild cognitive impairment using magnetoencephalography-derived functional connectivity. NeuroImage. (2015) 9:103–9. doi: 10.1016/j.nicl.2015.07.011, PMID:

129. Mandal I, Sairam N. New machine-learning algorithms for prediction of Parkinson's disease. Int J Syst Sci. (2014) 45:647–66. doi: 10.1080/00207721.2012.724114

130. Mundt JC, Freed DM, Greist JH. Lay person-based screening for early detection of Alzheimer's disease: development and validation of an instrument. J Gerontol B Psychol Sci Soc Sci. (2000) 55:P163–70. doi: 10.1093/geronb/55.3.P163, PMID:

131. Velazquez M, Lee Y. Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects. PLoS One. (2021) 16:e0244773. doi: 10.1371/journal.pone.0244773, PMID:

132. Minhad KN, Farayez A, Reaz MBI, Bhuiyan MAS, Samdin SB, Miraz MH. Early diagnosis of dementia patients by SPADE activity prediction algorithm. Measurement Sci Rev. (2023) 23:86–91. doi: 10.2478/msr-2023-0011

133. Ortiz A, Munilla J, Górriz JM, Ramírez J. Ensembles of deep learning architectures for the early diagnosis of the Alzheimer's disease. Int J Neural Syst. (2016) 26:1650025. doi: 10.1142/S0129065716500258, PMID:

Associated Data

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.